MENLO PARK, Calif., June 10, 2026
Subtle Medical has received U.S. FDA clearance for SubtleHD™(CT), a new artificial intelligence-powered image enhancement solution designed to improve computed tomography (CT) image quality by reducing noise and enhancing low-contrast detectability. The milestone marks the company’s first FDA-cleared CT imaging product and expands its growing portfolio of AI-powered imaging technologies across MRI, PET, and CT modalities. As healthcare systems face increasing imaging volumes and operational pressures, the new software aims to help radiology departments deliver more consistent and higher-quality imaging results while maximizing the value of existing scanner infrastructure. The approval represents Subtle Medical’s 11th FDA-cleared product and further strengthens its position as a leader in AI-driven medical imaging innovation.
FDA-Cleared AI Technology Enhances CT Image Quality
CT imaging remains one of the most widely utilized diagnostic tools in modern healthcare, supporting the detection, diagnosis, and monitoring of a broad range of diseases and medical conditions. However, healthcare providers often operate fleets consisting of multiple scanner generations, creating challenges in maintaining consistent image quality across systems. SubtleHD™(CT) was specifically developed to address these challenges by using advanced artificial intelligence algorithms to enhance image quality through noise reduction and improved image clarity.
The software integrates directly into existing clinical workflows without requiring changes to scanner hardware or operational processes. By improving image consistency across diverse CT systems, including older scanners that continue to play a critical role in patient care, the technology may help radiologists achieve greater diagnostic confidence while supporting healthcare organizations seeking cost-effective methods to optimize imaging performance.
Expanding Subtle Medical’s Multi-Modality AI Imaging Platform
Advertisement
The FDA clearance of SubtleHD™(CT) represents a significant strategic milestone in Subtle Medical’s evolution from a specialized imaging software provider into a comprehensive multi-modality AI imaging platform. The company has built a strong reputation through AI-powered solutions designed to improve image quality and scanning efficiency in MRI and PET imaging. With CT now added to its portfolio, Subtle Medical extends its reach into one of the largest and most frequently used imaging markets worldwide. Company leadership emphasized that healthcare organizations increasingly require solutions capable of delivering consistent imaging quality across multiple scanner types and technologies.
By leveraging artificial intelligence to standardize image quality, the company aims to support radiology departments facing growing patient demand while helping maximize the lifespan and performance of existing imaging assets. The vendor-neutral approach also allows providers to integrate AI enhancements without replacing current equipment, potentially accelerating adoption across hospitals and imaging centers.
Building the Future of AI-Driven Radiology Workflows
SubtleHD™(CT) joins an expanding suite of AI-powered products that includes SubtleHD™(MR), SubtleHD™(PET), SubtleSYNTH™, and SubtleALIGN™, all designed to improve imaging quality, workflow efficiency, and operational performance. Together, these solutions contribute to the company’s broader vision of creating a vendor-neutral AI Imaging Hub capable of supporting healthcare providers across multiple imaging modalities. The technology is already deployed on more than 1,300 scanners worldwide, demonstrating significant market adoption and clinical integration. Industry recognition has further elevated the company’s profile, with Subtle Medical being named among TIME’s World’s Top Healthcare Companies and receiving recognition from leading technology and healthcare innovation organizations.
As artificial intelligence continues to reshape radiology, the FDA clearance of SubtleHD™(CT) highlights the growing role of software-based innovations in enhancing diagnostic imaging quality, improving workflow efficiency, and enabling healthcare providers to deliver better patient outcomes without the need for costly hardware upgrades. The development underscores a broader trend toward AI-enabled imaging ecosystems that support precision diagnostics while addressing operational challenges across modern healthcare systems.
Source: Subtle Medical press release
